WilliamYKimMD
Oncology • Chapel Hill, NCGenitourinary Oncology, Hematologic Oncology
Professor, Medicine and Genetics, University of North Carolina at Chapel Hill School of Medicine
Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 919-966-4996Fax+1 919-843-5515
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1996 - 1999
The Warren Alpert Medical School of Brown UniversityClass of 1996
Certifications & Licensure
NC State Medical License 2006 - 2025
MA State Medical License 1999 - 2006
Clinical Trials
- Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer Start of enrollment: 2009 May 01
- Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy Start of enrollment: 2012 Jun 01
- Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- 56 citationsHIF, hypoxia and the role of angiogenesis in non-small cell lung cancerAutumn L. Jackson, Bing Zhou, William Y. Kim
Expert Opinion on Therapeutic Targets. 2010-09-20 - 700 citationsA Consensus Molecular Classification of Muscle-invasive Bladder Cancer.Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, Gottfrid Sjödahl, A. Gordon Robertson
European Urology. 2020-04-01 - 569 citationsImpact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Hussam Al-Deen Ashab, Nicholas Erho, Bas W.G. van Rhijn, Brian Winters
European Urology. 2017-10-01
Journal Articles
- VHL Substrate Transcription Factor ZHX2 as an Oncogenic Driver in Clear Cell Renal Cell CarcinomaEric Jonasch, Xian Chen, William Y Kim, W Kimryn Rathmell, Science Magazine
Press Mentions
Review Highlights Advances in Kidney Cancer Research and CareAugust 28th, 2024- Newsworthy from the School of Medicine, Week of August 12 – 19August 18th, 2021
GeneCentric Therapeutics to Present New Analyses of Molecular Characterization and Prediction of Treatment Response in Patients with Muscle Invasive Bladder Cancer (MIBC)February 13th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
